NCT01620528View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

872

Participants

Timeline

Start Date

May 22, 2012

Primary Completion Date

November 14, 2014

Study Completion Date

September 28, 2015

Conditions
Endometriosis
Interventions
DRUG

elagolix

oral tablet

OTHER

placebo

oral tablet

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01620528 - A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain | Biotech Hunter | Biotech Hunter